Israel has become the first country in the world to approved COVID-19 booster shots for immunocompromised adults.

Israel’s four health providers have been informed by the Ministry of Health that they can administer a third booster shot to adults with underlying immune problems.

The decision comes as the Delta variant continues to spread across the country, causing an acceleration in infections, even among previously vaccinated people.

On Sunday, the Health Ministry said there were 4,130 active cases domestically and 44 serious cases. Of these serious cases, around half are vaccinated.

Health Minister Nitzan Horowitz announced the planned move on Sunday and said that the ministry is evaluating whether to offer boosters to the whole population.

Sheba Medical Center was one of the first to respond and announced that it will give a third shot to dozens of heart-transplant patients on Tuesday.

The news comes on the heels of a new report that shows a possible growing correlation between vaccinated Israelis who have been infected with the Delta variant and those who were among the first to get the vaccine in January or February of this year, suggesting that the vaccine’s protection fades over time.

Experts, however, say that it is still too soon to draw conclusions.

On Thursday last week, Pfizer announced that it will ask U.S. and European regulators to authorize a third booster shot of its COVID-19 vaccine, saying that another shot within 12 months could dramatically boost immunity.

This article was first published by Israel21c.

JNS

Support
Jewish News Syndicate


With geographic, political and social divides growing wider, high-quality reporting and informed analysis are more important than ever to keep people connected.

Our ability to cover the most important issues in Israel and throughout the Jewish world—without the standard media bias—depends on the support of committed readers.

If you appreciate the value of our news service and recognize how JNS stands out among the competition, please click on the link and make a one-time or monthly contribution.

We appreciate your support.